Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

US multicentre neurosurgery trial for sealant:

This article was originally published in Clinica

Executive Summary

Focal is to begin a US multicentre clinical trial of its FocalSeal-S surgical sealant used for sealing cerebrospinal fluid leaks that occur following neurosurgery. The product has already proved promising in a European trial where researchers reported successful results in all 44 patients treated with the sealant following craniotomy or craniectomy procedures (see Clinica No 845, p 14). The Lexington, Massachusetts-based company, which is looking for a distribution partner in the US and Canada, said the product would be distributed elsewhere by Johnson & Johnson's Ethicon.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT079352

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel